SecBot SecBot
8-K ·Filed Nov 4, 2026

CRL

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
BULLISH
Impact 6/10
Horizonimmediate Processed12d 19h ago SEC0001100682-26-000156
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The second consecutive quarter of organic revenue growth and the guidance raise signal a sustained demand recovery in the DSA and Manufacturing segments. Watch for continued booking momentum in DSA and margin expansion from the CDMO divestiture benefit.

DirectionBullish
Confidencehigh
Horizonimmediate

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$326.29
T+0 close · Nov 4, 2026 · via day close
Latest settled
+5.03%
T+5 · $342.69 · next T+20 in 16d
Vs SPY
+5.94%
α at T+5
Latest observation
+6.59%
T+8 · FF3 residual α
  1. T+0 · Nov 4 $326.29entry
  2. T+1 · 12d ago −4.07%α +0.34% · $313.02
  3. T+5 · 6d ago +5.03%α +5.94% · $342.69
  4. T+8 · todayOpen
  5. T+20 · in 16d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Charles River reported Q3 2026 non-GAAP EPS of $3.09, beating the $2.97 consensus by 4.0%, on revenue of $982.7M versus the $960.4M consensus. Organic revenue grew 4.7% YoY, the second consecutive quarter of organic growth, and the company raised its full-year guidance for organic revenue to at least +1.5% and non-GAAP EPS to $11.35-$11.55, up from $11.15-$11.45.

Key Financial Metrics

EPS (Adj.)
$3.09
est $2.97 · +4.0% · GAAP: $6.86
Revenue
$982.7M
est $960.4M · +2.3% · -2.2% YoY
Rating
beat
Guidance
At least +1.5% organic growth
raised

Key Facts

  • Q3 2026 revenue $982.7M, down 2.2% reported but up 4.7% organically YoY
  • Non-GAAP EPS $3.09, up 27.2% YoY from $2.43
  • Non-GAAP operating margin expanded 330 bps to 23.0%
  • GAAP EPS $6.86 included a $5.06/share benefit from reversal of acquired tax reserves
  • Full-year organic revenue guidance raised to at least +1.5% from 0.0%-1.0%
  • Full-year non-GAAP EPS guidance raised to $11.35-$11.55 from $11.15-$11.45
  • DSA segment organic revenue grew 5.9%; Manufacturing organic revenue grew 7.4%
  • RMS segment organic revenue declined 0.6%

Financial Impact

Non-GAAP EPS of $3.09 beat consensus of $2.97 by $0.12 (4.0%); revenue of $982.7M beat consensus of $960.4M by $22.3M (2.3%)

revenuenon-GAAP EPSnon-GAAP operating marginguidance

Segment Breakdown

SegmentRevenueGrowth
Discovery and Safety Assessment (DSA)$596.3M-0.7%
Manufacturing Solutions$178.9M-6.2%
Research Models and Services (RMS)$207.5M-2.8%

Risk Factors

  • RMS segment organic revenue still declining 0.6% YoY
  • Reported revenue declined 2.2% due to divestitures, masking underlying organic growth
  • GAAP results heavily distorted by one-time tax benefit of $5.06/share

Market Snapshot

Exchange
NYSE
Sector
Services-Commercial Physical & Biological Research
Analyst Consensus
77% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001100682-26-000156
Document: crl-20261104.htm0001100682-26-000156
Document: 0001100682-26-000156-index-headers.html0001100682-26-000156
Document: 0001100682-26-000156-index.html0001100682-26-000156
Document: 0001100682-26-000156.txt0001100682-26-000156
8-K Data (Synthetic)0001100682-26-000156

Track record

17 reports on CRL

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +44.25% at T+60 after the Aug 5, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 4/10 Entry $333.18 Now $335.52 +0.70% settles Dec 15
  2. Nov 10, 20266d ago SC 13G/A Neutral 2/10 Entry $345.80 Now $335.52 −2.97% settles Dec 9
  3. Nov 9, 20267d ago 8-K Neutral 5/10 Entry $353.34 Now $335.52 −5.04% settles Dec 8
  4. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $313.02 Now $335.52 +7.19% settles Dec 4
  5. Nov 4, 202612d ago 8-K Bullish 6/10 Viewing Entry $326.29 Now $335.52 +2.83% settles Dec 3
  6. Oct 26, 202621d ago Insider Cluster Neutral 2/10 Entry $358.84 Now $335.52 −6.50% settles Nov 24
  7. Oct 22, 202625d ago 144 Neutral 2/10 Entry $345.37 Now $335.52 −2.85% settles Nov 20
  8. Oct 21, 202626d ago Institutional Cluster Bullish 4/10 Entry $339.66 Now $335.52 −1.22% settles Nov 19
  9. Sep 24, 20267w ago 8-K Bullish 6/10 Entry $294.44 to $339.66 Now $335.52 +13.95% ▲ +15.36% +15.78% vs SPY
  10. Aug 27, 202611w ago Insider Cluster Neutral 3/10 Entry $291.50 to $294.59 Now $335.52 +15.10% ▲ +1.06% +1.55% vs SPY
Showing 10 of 17

US Market Status

Market Closed · Opens in 6h 54m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 4, 2026